Search Within

Jianda Yuan

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (7)
  2. GSK Faculty (7)
  3. Molecular Pharmacology and Chemistry Program Faculty (7)
  4. Sloan Kettering Institute Faculty (7)
  5. Center for Hematologic Malignancies (6)
  6. Hematologic Malignancies Research (6)

More Groups

People
  1. Isabelle Riviere (4)
  2. James Young (4)
  3. Michel Sadelain (4)
  4. Glenn Heller (3)
  5. Jean-Baptiste Latouche (3)
  6. Jedd Wolchok (3)

More People

Years
  1. 2014 (1)
  2. 2010 (2)
  3. 2007 (1)
  4. 2006 (1)
  5. 2004 (1)
  6. 2003 (1)
Publications
  1. Blood (2)
  2. Cancer Immunology Research (1)
  3. Cancer Immunology, Immunotherapy (1)
  4. Journal of Immunology (1)
  5. Journal of Immunotherapy (1)
  6. Molecular Therapy (1)
Publishers
  1. American Society of Hematology (2)
  2. American Association for Cancer Research (1)
  3. Lippincott Williams & Wilkins (1)
  4. Nature Publishing Group (1)
  5. Springer (1)
  6. The American Association of Immunologists, Inc (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Paradoxical activation of T cells via augmented ERK signaling mediated by a RAF inhibitor
    Journal Article

    Callahan, M. K.; Masters, G.; Pratilas, C. A.; Ariyan, C.; Katz, J.; Kitano, S.; Russell, V.; Gordon, R. A.; Vyas, S.; Yuan, J. D.; more...
    Cancer Immunology Research (2014)

    Fulltext@MSK | Save
  • Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia
    Journal Article

    Maslak, P. G.; Dao, T.; Krug, L. M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Zhang, R.; Wolchok, J. D.; Yuan, J.; Pinilla-Ibarz, J.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer
    Journal Article

    Krug, L. M.; Dao, T.; Brown, A. B.; Maslak, P.; Travis, W.; Bekele, S.; Korontsvit, T.; Zakhaleva, V.; Wolchok, J.; Yuan, J.; more...
    Cancer Immunology, Immunotherapy (2010)

    Fulltext@MSK | Save
  • Scalable expansion of potent genetically modified human langerhans cells in a closed system for clinical applications
    Journal Article

    Yuan, J.; Kendle, R.; Ireland, J.; Heller, G.; Sadelain, M.; Young, J. W.; Riviere, I.
    Journal of Immunotherapy (2007)

    Fulltext@MSK | Save
  • Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent manner
    Journal Article

    Yuan, J.; Latouche, J. B.; Hodges, J.; Houghton, A. N.; Heller, G.; Sadelain, M.; Riviere, I.; Young, J. W.
    Journal of Immunology (2006)

    Fulltext@MSK | Save
  • Langerhans cells modified by gene transfer of full length CMV pp65 are more potent inducers of cytolytic T lymphocytes in a CD4-dependent manner than either CMV p495 gene-modified or p495 peptide-pulsed Langerhans cells
    Meeting Abstract

    Yuan, J.; Latouche, J. B.; Hodges, J.; Heller, G.; Riviere, I.; Sadelain, M.; Young, J. W.
    Molecular Therapy (2004)

    Fulltext@MSK | Save
  • Retroviral gene transduction is an effective means of providing ag for sustained presentation by CD34+-derived Langerhans cells, which stimulate potent antigen-specific cytolytic T lymphocytes
    Meeting Abstract

    Yuan, J. D.; Latouche, J. B.; Riviere, I.; Sadelain, M.; Young, J. W.
    Blood (2003)

    Fulltext@MSK | Save